Abstract
Background/Objectives:
Breast cancer is a disease characterised by both oxidative reactions and inflammation. However, few studies have focused on the oxidative and inflammatory biomarkers. The aim of the present study was to evaluate the association between oxidative stress markers and adiposity and clinical staging, as well as the association between the oxidative and the antioxidant biomarkers of women with breast cancer.
Subjects/Methods:
A total of 135 cases of breast cancer occurring in 2011 and 2012 were assessed. After exclusions, 101 pre- and post-menopausal women with clinical staging I to IV were eligible to participate in the study. The anthropometric evaluation was performed by collecting data on waist circumference, body mass index and body composition. The socioeconomic and clinical profiles were determined using a standard questionnaire. For the oxidative biomarkers, thiobarbituric acid reactive substances (TBARS), oxidative DNA damage (8-hydroxy-2-deoxyguanosine (8-OHdG)), low-density lipoprotein(−) (LDL(−)), autoantibody anti-LDL(−) and liposoluble antioxidants (α-tocopherol, retinol and β-carotene) were analysed. The data were analysed using differences in the mean values, correlation tests and multiple linear regression.
Results:
The antioxidant levels were higher in postmenopausal women with clinical staging I and II and negative lymph nodes. The TBARS level was associated with clinical staging. Adiposity was associated with levels of retinol and 8-OHdG, whereas LDL(−), 8-OHdG and TBARS were correlated with liposoluble antioxidants after adjusting for the confounders.
Conclusions:
The adiposity and clinical staging of patients were associated with oxidative stress. The oxidative and antioxidant biomarkers showed a negative correlation in patients with breast cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
American Institute for Cancer Research (AICR). World Cancer Research Fund Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. AICR: : Washington, DC, USA, 2007.
Siegel R, Jiemin M, Zhaohui Z, Ahmedin J . Cancer statistics 2014 CA Cancer J. Clin. 64: 9–29.
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Estimativa 2014: Incidência de Câncer no Brasil. INCA, Rio de Janeiro, Brazil, 2014. Available at http://www.inca.gov.br/estimativa/2014/.
Ramírez-Expósito MJ, Sánchez-López E, Cueto-Ureña C, Dueñas B, Carrera-González P, Navarro-Cecilia J et al. Circulating oxidative stress parameters in pre- and post-menopausal healthy women and in women suffering from breast cancer treated or not with neoadjuvant chemotherapy. Exp Gerontol 2014; 58C: 34–42.
Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB . Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010; 49: 1603–1616.
Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa MC, Ramirez-Tortosa CL, Granados-Principal S, Lorente JÁ et al. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. Crit Rev Oncol Hematol 2011; 80: 347–368.
Yeon J-Y, Suh Y-J, Kim S-W, Baik H-W, Sung C-J, Kim H-S et al. Evaluation of dietary factors in relation to the biomarkers of oxidative stress and inflammation in breast cancer risk. Nutrition 2011; 27: 912–918.
Jerby L, Wolf L, Denkert C, Stein GY, Hilvo M, Oresic M et al. Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer. Cancer Res 2012; 72: 5712–5720.
Thomson CA, Stendell-Hollis NR, Rock CL, Cussler EC, Flatt SW, Pierce JP . Plasma and dietary carotenoids are associated with reduced oxidative stress in women previously treated for breast cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 2008–2015.
Sova H, Jukkola-Vuorinen A, Puistola U, Kauppila S, Karihtala P . 8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer. Br J Cancer 2010; 102: 1018–1023.
Pande D, Negi R, Karki K, Khanna S, Khanna RS, Khanna H . Oxidative damage markers as possible discriminatory biomarkers in breast carcinoma. Transl Res 2012; 160: 411–418.
Hursting SD, Dunlap SM . Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue. Ann NY Acad Sci 2012; 1271: 82–87.
Kumaraguruparan R, Kabalimoorthy J, Nagini S . Correlation of tissue lipid peroxidation and antioxidants with clinical stage and menopausal status in patients with adenocarcinoma of the breast. Clin Biochem 2005; 38: 154–158.
Pansini F, Cervellati C, Guariento A, Stacchini MA, Castaldini C, Bernardi A et al. Oxidative stress, body fat composition, and endocrine status in pre-and postmenopausal women. Menopause 2008; 15: 112–118.
Badid N, Ahmed FZB, Merzouk H, Belbraouet S, Mokhtari N, Merzouk SA et al. Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer. Pathol Oncol Res 2010; 16: 159–167.
Panis C, Victorino V, Herrera A, Freitas L, De Rossi T, Campos F et al. Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer. Breast Cancer Res Treat 2012; 133: 881–888.
Victorino V, Panis C, Campos F, Cayres R, Colado-Simão A, Oliveira S et al. Decreased oxidant profile and increased antioxidant capacity in naturally postmenopausal women. Age 2012; 35: 1–11.
Karnofsky DA, Burchenal JH The clinical evaluation of chemotherapeutic agents in cancerIn: MacLeod CM (ed) Evaluation of Chemotherapeutic Agents. Columbia University Press: New York, NY, USA, 1949 pp 191–205.
Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W et al. Stages of reproductive aging workshop (STRAW). J Womens Health Gend Based Med 2001; 10: 843–848.
Garrett BE, Dube SR, Trosclair A, Caraballo RS, Pechacek TF . Cigarette smoking—United States, 1965–2008. MMWR Surveill Summ 2011; 60: 109–113.
Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA et al. Diet and lifestyle recommendations revision 2006A scientific statement from the American Heart Association nutrition committee. Circulation 2006; 114: 82–96.
World Health Organization Obesity: Preventing and Managing the GLOBAL Epidemic: Report of a WHO Consultation on Obesity, Geneva, 3–5 June 1997. World Health Organization: Geneva, Switzerland, 1998. Report no. WHO/NUT/NCD/98.1.
Lipschitz DA . Screening for nutritional status in the elderly. Prim Care 1994; 21: 55–67.
Lohman TG . Advances in Body Composition Assessment. Human Kinetics Publishers: Champaigne, IL, USA: Champaigne, IL, USA, 1992 pp 80.
Antolovich M, Prenzler PD, Patsalides E, McDonald S, Robards K . Methods for testing antioxidant activity. Analyst 2002; 127: 183–198.
Faulin S, do Espirito T, de Sena KCM, Rodrigues Telles AE, de Mattos Grosso D, Bernardi Faulin EJ et al. Validation of a novel ELISA for measurement of electronegative low-density lipoprotein. Clin Chem Lab Med 2008; 46: 1769–1775.
Santo Faulin TdE, de Sena-Evangelista KCM, Pacheco DB, Augusto EM, Abdalla DSP . Development of immunoassays for anti-electronegative LDL autoantibodies and immune complexes. Clin Chim Acta 2012; 413: 291–297.
Okoh V, Deoraj A, Roy D . Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer. Biochim Biophys Acta 2011; 1815: 115–133.
Fussell KC, Udasin RG, Smith PJ, Gallo MA, Laskin JD . Catechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells. Carcinogenesis 2011; 32: 1285–1293.
Žitnanová I, Rakovan M, Paduchová Z, Dvoráková M, Andrezálová L, Muchová J et al. Oxidative stress in women with perimenopausal symptoms. Menopause 2011; 18: 1249–1255.
Sánchez-Rodríguez MA, Zacarías-Flores M, Arronte-Rosales A, Correa-Muñoz E, Mendoza-Núñez VM . Menopause as risk factor for oxidative stress. Menopause 2012; 19: 361–367.
Pande D, Karki K, Negi R, Khanna S, Khanna RS, Khanna H . NF-κB p65 subunit DNA-binding activity: association with depleted antioxidant levels in breast carcinoma patients. Cell Biochem Biophys 2013; 67: 1–7.
Şener DE, Gönenç A, Akıncı M, Torun M . Lipid peroxidation and total antioxidant status in patients with breast cancer. Cell Biochem Funct 2007; 25: 377–382.
Silva IT, Mello A, Sanches L, Abdalla D, Damasceno N . Is plasma alpha-tocopherol associated with electronegative LDL in obese adolescents? J Nutr Sci Vitaminol 2012; 59: 100–107.
Mafra D, Santos FR, Lobo JC, de Mattos Grosso D, Barreira AL, LGC Velarde et al. Alpha-tocopherol supplementation decreases electronegative low-density lipoprotein concentration [LDL (−)] in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 1587–1592.
Pereira EC, Bertolami MC, Faludi AA, Sevanian A, Abdalla DS . Antioxidant effect of simvastatin is not enhanced by its association with α-tocopherol in hypercholesterolemic patients. Free Radic Biol Med 2004; 37: 1440–1448.
Delimaris I, Faviou E, Antonakos G, Stathopoulou E, Zachari A, Dionyssiou-Asteriou A . Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. Clin Biochem 2007; 40: 1129–1134.
Khaidakov M, Mehta JL . Oxidized LDL triggers pro-oncogenic signaling in human breast mammary epithelial cells partly via stimulation of MiR-21. PLoS One 2012; 7: e46973.
Avogaro P, Bon GB, Cazzolato G . Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988; 8: 79–87.
Estruch M, Sánchez-Quesada JL, Ordóñez Llanos J, Benítez S . Electronegative LDL: a circulating modified LDL with a role in inflammation. Mediators Inflamm 2013; 2013: 181324.
Mello APQ, da Silva IT, Abdalla DSP, Damasceno NRT . Electronegative low-density lipoprotein: origin and impact on health and disease. Atherosclerosis 2011; 215: 257–265.
Macciò A, Madeddu C . Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications. Sci World J 2011; 11: 2020–2036.
Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, Bingham S et al. Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol 2003; 158: 1–13.
Jenab M, Slimani N, Bictash M, Ferrari P, Bingham S . Biomarkers in nutritional epidemiology: applications, needs and new horizons. Hum Genet 2009; 125: 507–525.
Pollard J, Wild CP, White KL, Greenwood DC, Cade JE, Kirk SF . Comparison of plasma biomarkers with dietary assessment methods for fruit and vegetable intake. Eur J Clin Nutr 2003; 57: 988–998.
Keogh RH, White IR, Rodwell SA . Using surrogate biomarkers to improve measurement error models in nutritional epidemiology. Stat Med 2013; 32: 3838–3861.
Hodge AM, Simpson JA, Fridman M, Rowley K, English DR, Giles GG et al. Evaluation of an FFQ for assessment of antioxidant intake using plasma biomarkers in an ethnically diverse population. Public Health Nutr 2009; 12: 2438–2447.
Wang Y, Yang M, Lee SG, Davis CG, Koo SI, Chun OK . Dietary total antioxidant capacity is associated with diet and plasma antioxidant status in healthy young adults. J Acad Nutr Diet 2012; 112: 1626–1635.
Frankenfeld CL, Lampe JW, Shannon J, Gao DL, Li W, Ray RM et al Fruit and vegetable intakes in relation to plasma nutrient concentrations in women in Shanghai Public Health Nutr 2012; 15: 167–175.
Acknowledgements
This study was supported, in part, by the Sao Paulo Research Foundation (FAPESP), Brazil (grant 2010/19207-6; 2011/15590-2) and also, in part, by FAPESP process: 2010/19207-6; 2011/15590-2.
Author Contributions
AAFC performed data analysis and drafted the manuscript. SMMLV was involved in data collection and analysis. LAL, MdRDdOL, PHdCR and THPE were involved in data analysis and critical analysis. NRTD performed data analysis and final revision and critical analysis of the manuscript. All authors read and approved the final draft of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Carioca, A., Verde, S., Luzia, L. et al. Association of oxidative stress biomarkers with adiposity and clinical staging in women with breast cancer. Eur J Clin Nutr 69, 1256–1261 (2015). https://doi.org/10.1038/ejcn.2015.84
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2015.84